Sort   by:  
 Page size 
UnknownNon-viral chimeric antigen receptor (CAR) T cells going viral.
Not available
S-EPMC10139995 | biostudies-literature
UnknownALK mutations conferring differential resistance to structurally diverse ALK inhibitors.
Not available
S-EPMC3382103 | biostudies-literature
UnknownHomology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.
Not available
S-EPMC10291796 | biostudies-literature
UnknownP1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT
Not available
S-EPMC9431345 | biostudies-literature
UnknownA framework for identification of actionable cancer genome dependencies in small cell lung cancer.
Not available
S-EPMC3479457 | biostudies-literature
UnknownAn anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.
Not available
S-EPMC10897622 | biostudies-literature
Unknownc-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors.
Not available
S-EPMC12866126 | biostudies-literature
UnknownSystematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.
Not available
S-EPMC5622049 | biostudies-literature
UnknownFrequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Not available
S-EPMC3990281 | biostudies-literature
Sort   by:  
 Page size